CA Cancer J Clin 2009, 59 (4) : 225–249.CrossRefPubMed 2. Wright ME, Peters U, Gunter MJ, Moore SC, Lawson KA, Yeager M, Weinstein SJ, Snyder K, Virtamo J, Albanes D: Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk. Cancer Res 2009, 69 (4) : 1429–1438.CrossRefPubMed 3. Cheung WY, Liu G: Genetic variations in esophageal cancer risk and prognosis. Gastroenterol Clin North Am 2009, 38 (1) : 75–91.CrossRefPubMed 4. Hill RP, Marie-Egyptienne

DT, Hedley DW: Cancer stem cells, hypoxia and metastasis. Semin Radiat Oncol 2009, 19 (2) : 106–111.CrossRefPubMed 5. Smaldone MC, Maranchie JK: Clinical implications of hypoxia inducible factor in renal cell carcinoma. Urol Oncol 2009, 27 (3) : 238–245.PubMed 6. Tanimoto K, Yoshiga K, Eguchi H, Kaneyasu HDAC phosphorylation M, Ukon K, Kumazaki T, Oue N, Yasui W, Imai K, Nakachi K, Poellinger L, Nishiyama M: Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation

capacity, implying clinical significance. Carcinogenesis 2003, 24: 1779–1783.CrossRefPubMed 7. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D: Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. Cancer Res 1999, 59: 5830–5835.PubMed 8. Munoz-Guerra MF, Fernandez-Contreras ME, Moreno AL, Martin ID, Herraez B, Gamallo C: Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer. Ann Surg Oncol 2009, 16 (8) : HSP990 cost 2351–2358.CrossRefPubMed 9. Foley R, Marignol L, Thomas AZ, Cullen IM, Perry AS, Tewari P, O’Grady Galeterone A, Kay E, Dunne B, Loftus B, Watson WR, Fitzpatrick JM, Woodson K, Lehman T, Hollywood D, Lynch TH, Lawler M: The HIF-1α C1772T polymorphism may be associated with susceptibility to clinically JQ-EZ-05 solubility dmso localised prostate cancer but not with elevated expression of hypoxic biomarkers. Cancer Biol Ther 2009, 8 (2) : 118–124.CrossRefPubMed 10. Li H, Bubley GJ, Balk SP, Gaziano JM,

Pollak M, Stampfer MJ, Ma J: Hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms, circulating insulin-like growth factor binding protein (IGFBP)-3 levels and prostate cancer. Prostate 2007, 67 (12) : 1354–1361.CrossRefPubMed 11. Orr-Urtreger A, Bar-Shira A, Matzkin H, Mabjeesh NJ: The homozygous P582S mutation in the oxygen-dependent degradation domain of HIF-1 alpha is associated with increased risk for prostate cancer. Prostate 2007, 67 (1) : 8–13.CrossRefPubMed 12. Chau CH, Permenter MG, Steinberg SM, Retter AS, Dahut WL, Price DK, Figg WD: Polymorphism in the hypoxia-inducible factor 1 alpha gene may confer susceptibility to androgen-independent prostate cancer. Cancer Biol Ther 2005, 4 (11) : 1222–1225.PubMed 13. Lee JY, Choi JY, Lee KM, Park SK, Han SH, Noh DY, Ahn SH, Kim DH, Hong YC, Ha E, Yoo KY, Ambrosone CB, Kang D: Rare variant of hypoxia-inducible factor-1alpha (HIF-1A) and breast cancer risk in Korean women. Clin Chim Acta 2008, 389 (1–2) : 167–170.